HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Mechanism of the alternation cycle length phenomenon during intravenous verapamil for termination of atrioventricular reciprocating tachycardia].

Abstract
The electrophysiologic-pharmacologic test of verapamil on 33 patients with the Wolff-Parkinson-White syndrome with atrioventricular reciprocating tachycardia (AVRT) was studied. During intravenous verapamil for termination of AVRT, the alternating cycle length phenomenon was observed in 13 cases (39%). On the basis of the observations we attributed the phenomenon to alternating conduction between early and late phase of the AV nodal relative refractory period due to the AV nodal refractory period lengthened by verapamil except a few patients in whom verapamil unmasked the presence of concealed accessory pathways or dual AV nodal pathways as hypothesized by some scholars.
AuthorsR Y Du, N Z Zhang
JournalZhonghua xin xue guan bing za zhi (Zhonghua Xin Xue Guan Bing Za Zhi) Vol. 21 Issue 2 Pg. 85-6, 122-3 (Apr 1993) ISSN: 0253-3758 [Print] China
PMID8223169 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Verapamil
Topics
  • Adolescent
  • Adult
  • Child
  • Electrophysiology
  • Female
  • Humans
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Refractory Period, Electrophysiological (drug effects)
  • Tachycardia, Atrioventricular Nodal Reentry (drug therapy, physiopathology)
  • Verapamil (administration & dosage, therapeutic use)
  • Wolff-Parkinson-White Syndrome (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: